The effect of yokukansan and shoseiryuto on Atopic Dermatitis with itch and QOL disorders.-an explaratory research

Trial Profile

The effect of yokukansan and shoseiryuto on Atopic Dermatitis with itch and QOL disorders.-an explaratory research

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 16 May 2016

At a glance

  • Drugs TJ 54 (Primary) ; Sho seiryu to
  • Indications Atopic dermatitis
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 14 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top